Use of Fludrocortisone for Hyperkalemia in Chronic Kidney Disease Not Yet on Dialysis.
Eun Kyoung LeeWon Seok Yang
Published in: Electrolyte & blood pressure : E & BP (2024)
In pre-dialysis CKD patients, fludrocortisone at low doses effectively reduced serum potassium levels; however, sodium retention was a common adverse effect.